Investigating the effectiveness of vitamin E drug in reducing the incidence of chronic neurotoxicity caused by oxaliplatin drug

Phase 2

• Conditions: Drug-induced neurotoxicity.; Drug-induced neurotoxicity; 62.0

• Registration Number: IRCT20180313039085N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Colon cancer patients are candidates for adjuvant chemotherapy

Exclusion Criteria

Patients' unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurotoxicity. Timepoint: 1, 2, 3, 4, 5 and 6 months after the start of the study. Method of measurement: NCI-CTCAE-ver3 criterion.